PubMed=1497905; DOI=10.1165/ajrcmb/7.2.161
Yang P.-C., Luh K.-T., Wu R., Wu C.-W.
Characterization of the mucin differentiation in human lung adenocarcinoma cell lines.
Am. J. Respir. Cell Mol. Biol. 7:161-171(1992)

PubMed=9308922; DOI=10.1165/ajrcmb.17.3.2837
Chu Y.-W., Yang P.-C., Yang S.-C., Shyu Y.-C., Hendrix M.J.C., Wu R., Wu C.-W.
Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line.
Am. J. Respir. Cell Mol. Biol. 17:353-360(1997)

PubMed=11431363
Chen J.J.W., Peck K., Hong T.-M., Yang S.-C., Sher Y.-P., Shih J.-Y., Wu R., Cheng J.-L., Roffler S.R., Wu C.-W., Yang P.-C.
Global analysis of gene expression in invasion by a lung cancer model.
Cancer Res. 61:5223-5230(2001)

PubMed=16354588; DOI=10.1593/neo.05640; PMCID=PMC1501169
Shieh Y.-S., Lai C.-Y., Kao Y.-R., Shiah S.-G., Chu Y.-W., Lee H.-S., Wu C.-W.
Expression of axl in lung adenocarcinoma and correlation with tumor progression.
Neoplasia 7:1058-1064(2005)

PubMed=24705471; DOI=10.1371/journal.pone.0094065; PMCID=PMC3976390
Sher Y.-P., Wang L.-J., Chuang L.-L., Tsai M.-H., Kuo T.-T., Huang C.-C., Chuang E.Y., Lai L.-C.
ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells.
PLoS ONE 9:e94065.1-e94065.12(2014)

PubMed=25060522; DOI=10.1158/0008-5472.CAN-13-2995
Lin C.-Y., Chen H.-J., Huang C.-C., Lai L.-C., Lu T.-P., Tseng G.-C., Kuo T.-T., Kuok Q.-Y., Hsu J.L., Sung S.-Y., Hung M.-C., Sher Y.-P.
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.
Cancer Res. 74:5229-5243(2014)